ICH Q7 clause 4: Buildings and facilities

Facility design is foundational to GMP compliance. Design must support: cleaning (smooth surfaces, accessible corners), maintenance (adequate access, proper lighting), contamination prevention (appropriate layout, separation of operations), and operational efficiency. Location considerations include environmental factors (nearby industries, weather patterns) and logistical considerations (supplier access, utility availability). Microbial controls scale with API sensitivity.

Contamination minimization through design includes: physical separation of incompatible operations (e.g., potent and non-potent materials), unidirectional flow to prevent backtracking, appropriate air handling with pressure cascades, cleanable surface materials, minimization of dust-generating areas. For microbially sensitive products, additional controls like HEPA filtration, positive pressure, and sanitization programs are needed.

Each activity needs a defined area or control system. 'Defined areas' typically means physically separated rooms or zones. 'Other control systems' allows electronic segregation with effective access controls (e.g., a single warehouse with ERP-based status tracking). The list enumerates critical activities: receiving/quarantine, sampling, storage, production, packaging, laboratory. Missing any of these areas is a significant gap.

Open handling (e.g., charging powders, sampling, discharge) is a high-contamination-risk activity. Dedicated clean areas with appropriate controls minimize risk. Flow patterns should be unidirectional: materials move through the facility without crossing contaminated areas; personnel flow separates from material flow where possible; equipment moves through cleaning/sanitization as needed. Air handling supports flow by providing pressure differentials and cleanable airflow.

Separation can be physical (dedicated rooms, equipment) or temporal (campaign-based operations on shared equipment). Physical separation is required for: highly potent materials (hormones, cytotoxics), beta-lactams, biological materials. Temporal separation with thorough cleaning validation may be acceptable for lower-risk products. Risk assessment determines the required level.

Crowded facilities are error-prone. Adequate space allows for proper placement of materials with separation between different products/batches, unobstructed movement of personnel and equipment, and dedicated storage areas. Physical markings (floor tape, zones) help identify placement locations. Space planning during facility design considers maximum expected inventory and activity levels.

Laboratory separation from production prevents cross-contamination and enables proper environmental control for sensitive analytical work. However, in-process control labs may be located close to production for efficiency. The key question: does the co-location compromise either the lab work or the production? Common problems: vibration affecting balances, dust contaminating samples, solvents interfering with HPLC, heat affecting analytical equipment.

Utility impact on quality varies: process water directly contacts the product (highest impact), gases and compressed air contact product surfaces (medium impact), HVAC affects environmental quality (varies by area). Critical utilities require qualification (IQ/OQ/PQ) and ongoing monitoring. Monitoring frequency depends on criticality and stability. Out-of-limit excursions trigger investigation and product impact assessment.

HVAC design affects both product quality and operator safety. Key elements: adequate air changes per hour (typically 10-20 for GMP areas), HEPA filtration for clean areas, pressure differentials to prevent cross-contamination, humidity control for moisture-sensitive processes, temperature control for operator comfort and process needs. Once-through air (no recirculation) is common for dusty or sensitizing materials.

Pipe identification prevents cross-connection errors during maintenance or modifications. Common approaches: color coding, flow direction arrows, content labels at intervals along the pipe, tags at connections. The identification scheme should be documented and consistent across the facility. P&IDs provide the documented system for identifying piping within control systems.

Floor drains can be contamination sources if not properly designed. Air breaks prevent back-siphonage from sewer lines into processing areas. Traps prevent sewer gas entry. Covers prevent pest ingress. Drain locations should facilitate cleaning (liquid waste draining to collection) without creating contamination paths to clean areas. Drain trap water should be regularly flushed to maintain water seal.

Heating/cooling systems include steam, hot water, chilled water, glycol cooling, cryogenic cooling. Direct contact (e.g., steam injection, cooling via direct contact) requires higher quality media. Indirect contact (jacket heating/cooling) has lower risk but still requires leak prevention and appropriate media selection. Heat transfer fluids should be compatible with the process and selected based on temperature ranges.

Water quality must be appropriate for the API. WHO drinking water is the absolute minimum for process contact. Higher grades (Purified Water, Water for Injection) are required for more sensitive APIs. The water quality specifications must cover: chemical attributes (pH, conductivity, TOC), microbial limits (total count, specific organisms), and for injectable APIs, endotoxin limits. Specifications should be justified by the intended use.

APIs for injectable products need enhanced water quality in final steps. Typically: Purified Water (USP) or Water for Injection (WFI) depending on proximity to the sterile drug product. WFI is the highest quality with strict endotoxin limits (< 0.25 EU/mL). The treatment train typically includes: pretreatment, reverse osmosis, deionization, distillation (for WFI), storage with recirculation, and point-of-use filtration.

A complete water program requires: written specifications, a qualified water system capable of meeting specs, sampling plan with frequency based on risk, validated test methods, trending of results, investigation of excursions. Sampling points should represent worst-case locations (furthest from treatment, dead legs if any, use points). Testing frequency is typically daily for microbiological and continuous for conductivity/TOC.

Water systems are living systems that require ongoing care. Microbial biofilm growth is the primary risk. Controls include: recirculating loops (maintaining velocity), hot water storage (inhibits growth), periodic sanitization (heat or chemical), filter replacements, and UV treatment where used. Sanitization validation demonstrates that the procedure actually reduces microbial burden. Maintenance activities are documented to show compliance with schedules.

Most APIs are non-sterile (intended for oral, topical, or other non-injectable dosage forms) and don't require WFI. However, water treatment is often still used to remove specific contaminants (e.g., chlorine that could affect reactions, hardness causing scale, iron affecting catalysts). The treatment process and final water quality must be validated for the intended use. Action limits trigger investigation before specs are breached.

Beta-lactam antibiotics (penicillins, cephalosporins) can cause severe allergic reactions even at trace levels — so they require dedicated facilities with their own air handling. Cytotoxic APIs, hormones, and highly potent compounds typically also require dedicated facilities unless exceptionally rigorous cleaning can be validated. This is one of the most important clauses in ICH Q7 and triggers significant facility investment for some products.

Biological materials require BSL (biosafety level) appropriate facilities: BSL-1 for non-pathogenic, BSL-2 for moderate-risk, BSL-3 for serious, BSL-4 for lethal. Each level has specific design requirements including containment, air handling (HEPA exhaust), access controls, and operator protection. Classical fermentation products typically use BSL-1, while pathogenic organisms (rare in API manufacturing) require higher levels.

Potent APIs (occupational exposure limit < 10 μg/m³) require enhanced containment. The containment strategy uses the hierarchy of controls: engineering (best), administrative (procedures), PPE (last line). Engineering controls include: isolators for highest potency, downflow booths for moderate, local exhaust for lower. Procedural controls: gowning, limited access, campaign production. PPE: respiratory protection, chemical suits.

Cytotoxic APIs (anti-cancer drugs) present dual risks: patient harm from cross-contamination and occupational health harm to workers. Dedicated facilities are strongly preferred. Where shared facilities are used (sometimes necessary for commercial reasons), validation must be rigorous: OEL-based cleaning limits (often in the ng/cm² range), orthogonal analytical methods, worst-case product validation, environmental monitoring, worker exposure verification.

Lighting adequacy varies by task: visual inspection requires high illumination (500+ lux), general work areas moderate (300 lux), storage lower (150 lux). Lighting fixtures in production areas should be sealed to prevent insect accumulation and dust infiltration. Emergency lighting for safe egress is required by building codes. Dim or shadowed areas create contamination and safety risks.

Waste management prevents contamination and environmental harm. Key controls: segregated waste streams (general, hazardous, biological, cytotoxic), clearly labeled containers, timely removal to prevent accumulation, proper disposal per regulations (RCRA, EPA, etc.). Waste water treatment or disposal per permits. Contractors handling hazardous waste must be qualified and documented.

Building maintenance keeps facilities suitable for GMP use. Common issues include: paint peeling, wall cracks, ceiling damage, floor wear, window failures, HVAC degradation. Maintenance must be planned and performed without creating contamination or disrupting operations. Contractors performing maintenance need GMP awareness training. Maintenance during production requires contamination controls (partitions, vacuum systems).

Sanitation procedures integrate with waste disposal to maintain clean facilities. Written procedures define: who is responsible, what is cleaned, how frequently, what cleaning materials/tools, what verification. Waste procedures cover: routine waste streams, spill response, accident cleanup. Emergency procedures for large spills or unusual events prevent escalation.

Cleaning records document compliance with schedules. Content: date, time, area cleaned, cleaning agent used, operator signature. Verification ranges from visual inspection (minimum) to analytical testing (for critical surfaces). Environmental monitoring data correlates cleaning effectiveness with microbial control. Trending reveals cleaning program weaknesses.